The U.Okay. is in the midst of a falling out with big pharma over drug pricing. Merck has walked away from a £1 billion facility in London and pulled its analysis actions altogether. Now Eli Lilly, Sanofi and AstraZeneca are all rethinking their investments in the nation. CNBC’s Ritika Gupta discusses with Jimmy Muchechetere, international healthcare & industrials fairness analysis analyst at Investec.
07:41
Mon, Sep 15 20253:32 AM EDT